GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (FRA:PDXN) » Definitions » Cyclically Adjusted Price-to-FCF

Pro-Dex (FRA:PDXN) Cyclically Adjusted Price-to-FCF : 286.15 (As of Jun. 05, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Pro-Dex Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Pro-Dex's current share price is €37.20. Pro-Dex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €0.13. Pro-Dex's Cyclically Adjusted Price-to-FCF for today is 286.15.

The historical rank and industry rank for Pro-Dex's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:PDXN' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 22.32   Med: 51.85   Max: 2513
Current: 289.63

During the past years, Pro-Dex's highest Cyclically Adjusted Price-to-FCF was 2513.00. The lowest was 22.32. And the median was 51.85.

FRA:PDXN's Cyclically Adjusted Price-to-FCF is ranked worse than
95.16% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 36.435 vs FRA:PDXN: 289.63

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pro-Dex's adjusted free cash flow per share data for the three months ended in Mar. 2025 was €0.159. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.13 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pro-Dex Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Pro-Dex's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Cyclically Adjusted Price-to-FCF Chart

Pro-Dex Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.81 - - 612.97 98.00

Pro-Dex Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.93 98.00 128.92 442.91 335.63

Competitive Comparison of Pro-Dex's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Pro-Dex's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Cyclically Adjusted Price-to-FCF falls into.


;
;

Pro-Dex Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Pro-Dex's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=37.20/0.13
=286.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Pro-Dex's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.159/134.9266*134.9266
=0.159

Current CPI (Mar. 2025) = 134.9266.

Pro-Dex Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.076 100.684 -0.102
201509 -0.138 100.392 -0.185
201512 0.064 99.792 0.087
201603 -0.170 100.470 -0.228
201606 0.271 101.688 0.360
201609 -0.016 101.861 -0.021
201612 0.101 101.863 0.134
201703 0.227 102.862 0.298
201706 0.274 103.349 0.358
201709 0.183 104.136 0.237
201712 -0.065 104.011 -0.084
201803 0.070 105.290 0.090
201806 0.235 106.317 0.298
201809 0.031 106.507 0.039
201812 0.165 105.998 0.210
201903 0.223 107.251 0.281
201906 -0.021 108.070 -0.026
201909 0.186 108.329 0.232
201912 0.305 108.420 0.380
202003 -0.082 108.902 -0.102
202006 0.547 108.767 0.679
202009 -0.209 109.815 -0.257
202012 -0.974 109.897 -1.196
202103 -0.943 111.754 -1.139
202106 -0.044 114.631 -0.052
202109 0.414 115.734 0.483
202112 0.301 117.630 0.345
202203 0.002 121.301 0.002
202206 -1.432 125.017 -1.546
202209 0.742 125.227 0.799
202212 -0.234 125.222 -0.252
202303 0.568 127.348 0.602
202306 0.123 128.729 0.129
202309 0.070 129.860 0.073
202312 0.020 129.419 0.021
202403 1.034 131.776 1.059
202406 0.244 132.554 0.248
202409 0.399 133.029 0.405
202412 -1.343 133.157 -1.361
202503 0.159 134.927 0.159

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pro-Dex  (FRA:PDXN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Pro-Dex Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Pro-Dex Headlines

No Headlines